Compare
Inspire Medical Systems, Inc. vs Orthofix Medical Inc. vs Tandem Diabetes Care Inc vs iRhythm Holdings, Inc.
| Latest fiscal year | Inspire Medical Systems, Inc. INSP | Orthofix Medical Inc. OFIX | Tandem Diabetes Care Inc TNDM | iRhythm Holdings, Inc. IRTC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $911.98M | $822.31M | $1.01B | $747.14M |
| Revenue growth (YoY) | +13.6% | +2.9% | +7.9% | +26.2% |
| Gross margin | 85.4% | 68.8% | 53.8% | 70.6% |
| Operating margin | 5.6% | -9.9% | -18.5% | -7.7% |
| Net margin | 15.9% | -11.2% | -20.2% | -6.0% |
| Net income | $145.42M | -$92.19M | -$204.71M | -$44.55M |
| EPS (Diluted) | $4.89 | -$2.33 | -$3.04 | -$1.39 |
| Operating cash flow | $116.98M | $33.35M | -$9.72M | $80.86M |
| Free cash flow | $78.48M | -$1.28M | -$29.67M | $34.52M |
| Cash & equivalents | $104.81M | $82.03M | $90.63M | $236.01M |
| Total assets | $907.32M | $850.65M | $881.11M | $1.02B |
| Total liabilities | $126.16M | $400.61M | $725.94M | $867.30M |
| Shareholders' equity | $781.16M | $450.04M | $155.17M | $152.75M |
| Return on year-end equity | 18.6% | -20.5% | -131.9% | -29.2% |
| Shares outstanding | 28.58M | 39.83M | 68.29M | 32.30M |
Revenue, most recent five fiscal years
| Fiscal year | Inspire Medical Systems, Inc. | Orthofix Medical Inc. | Tandem Diabetes Care Inc | iRhythm Holdings, Inc. |
|---|---|---|---|---|
| Latest | $911.98M Ended 2025-12-31 | $822.31M Ended 2025-12-31 | $1.01B Ended 2025-12-31 | $747.14M Ended 2025-12-31 |
| 1 year earlier | $802.80M Ended 2024-12-31 | $799.49M Ended 2024-12-31 | $940.20M Ended 2024-12-31 | $591.84M Ended 2024-12-31 |
| 2 years earlier | $624.80M Ended 2023-12-31 | $746.64M Ended 2023-12-31 | $747.72M Ended 2023-12-31 | $492.68M Ended 2023-12-31 |
| 3 years earlier | $407.86M Ended 2022-12-31 | $460.71M Ended 2022-12-31 | $801.22M Ended 2022-12-31 | $410.92M Ended 2022-12-31 |
| 4 years earlier | $233.39M Ended 2021-12-31 | $464.48M Ended 2021-12-31 | $702.80M Ended 2021-12-31 | $322.82M Ended 2021-12-31 |